22 May 2013
Keywords: fda, backs, avapro, use, diabetic, renal, disease
Article | 21 January 2002
The US Food and Drug Administration is in favor of the approval ofSanofi-Synthelabo/Bristol-Myers Squibb's Avapro (irbesartan) as a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 January 2002
28 January 2002
21 May 2013
© 2013 thepharmaletter.com